

Get in the KNOW
on LA Startups & Tech
XMeet the Startup That Wants To Deliver Ketamine to Your Door
David Shultz
David Shultz reports on clean technology and electric vehicles, among other industries, for dot.LA. His writing has appeared in The Atlantic, Outside, Nautilus and many other publications.
Ketamine is on the come up in the pharmaceutical world. Once confined to nightclubs and operating rooms, the drug is quickly gaining recognition as a valuable tool for treating mental health disorders including depression and anxiety.
Amid these rising tides, Wondermed has emerged, offering telehealth consultations and, potentially, the ability to deliver the drug right to your doorstep—all while building out a virtual platform and collecting data on how to use the molecule more effectively.
At the moment, the company provides a mail order service for courses of ketamine lozenges to those who’ve been prescribed the drug along with a telehealth software bridge between doctor and patient. Wondermed currently operates in five states — California, Texas, Florida, New York and Connecticut, though it plans to expand to another eight to 10 states in the next two weeks.
In the long run however, its plans are much bigger than being a link between doctors and patients.
“We generate more than 3,000 data points on every patient that comes into the funnel, and actually receives the medication,” says co-founder & Managing Director Jose Aycart.
His company is building out its online platform to collect and analyze patient data and provide mental health support services that may be useful, regardless of whether or not a patient is taking ketamine.
These data show in granular detail how ketamine therapies work. Does the route of administration matter? Does time of day matter? What types of patients are most likely to experience positive outcomes? It’s this data that represents the biggest business opportunity for Wondermed. The specifics of the monetization are still being worked out, but Aycart says it will never sell anonymized patient data to other companies.
Wondermed is in the midst of a seed funding round, targeting $7 million by the end of the month; It’s raised $5.6 million so far.
The company makes a bit of revenue by charging patients for consultations, but in the event that a patient doesn’t wind up using Wondermed’s platform, the consultation fee is refunded. For patients who are prescribed ketamine, the company charges only as much as the drugs cost them ($249 per month, which includes four doses), so neither Wondermed nor the physicians in its employ are incentivized to over-prescribe.
The drugs themselves are supplied by Tailor Made Compounding, a pharmacy in Nicholasville, Kentucky, and Wondermed is working on additional contracts in the pipeline with several other suppliers.
. Wondermed’s transformation comes as ketamine, which has typically been restricted to use as a general anesthetic, is quickly gaining recognition as a valuable tool for treating mental health disorders like depression and anxiety.
“What I’ve found interesting is how rapidly this field has emerged,” says Steven Grant, a drug and addiction researcher who spent 25 years at the National Institute on Drug Abuse and is now retired.

Ketamine is a simple organic molecule that first gained clinical popularity in the 1960s as an anesthetic. It produces a dissociative state in patients and dulls pain. Once in the bloodstream, the molecule travels to the brain where it binds to a protein called NMDA on the surface of neurons. NMDA has a variety of jobs, but it’s best-known for its role in learning, memory, and neuroplasticity—or the brain’s ability to form new pathways between neurons.
While the research into why ketamine is such an effective treatment for depression and anxiety is ongoing, the consensus so far is that the molecule’s power comes from this ability to rewrite or rewire the brain’s circuitry. If you’ve ever had an anxiety attack or a depressive episode, it can often feel like you’re stuck in a mental loop. Ketamine, it seems, offers a way to break that loop.
“It was this idea that you're increasing your neurological connections in the brain,” says Aycart. “You have the opportunity now to spark new forms of thought, new forms of emotion, or even new ideas.”
Unlike selective serotonin reuptake inhibitors (SSRIs) and other traditional drugs used to treat depression, ketamine’s effects are fast-acting—often appearing within minutes or hours of administration—and don’t require taking the drug daily.
“It really is revolutionary, and that’s why now more than ever, people are starting to get access to it, and companies like ourselves are really trying to bring it to people as an alternative form of medicine,” says Aycart.
Grant says the rise of ketamine clinics and telehealth services like Wondermed are likely a net positive because they increase patient access to drugs patients need, but he also has reservations about how the therapies are being applied.
Many of these psychoactive drugs—especially ketamine—are intended to be used in tandem with therapy, or at least under the supervision of a trained professional. Increasing the brain’s plasticity is a valuable tool for breaking out of depressive loops, but unless a professional is there to help the patient settle into a healthier mental pattern, the full benefits may be left on the table.
Wondermed offers a variety of supplementary support and strategies along with the drugs themselves, but taking advantage of these tools is left to the patient’s discretion. Grant would like to see a larger focus on extending and expanding that auxiliary support.
The company says it’s focused on building out the platform’s nonmedicinal mental health strategies—things like breathwork, meditation, music therapy—and adding them to an app. If they can get enough people on board, the eventual plan could be to sell health insights back to patients through a subscription model or something similar. They may even patent their own psychedelic molecules in the future. But all of this is likely quite a ways out.
“What we're trying to do is very new, and the landscape yet hasn't been built out,” says Aycart.
Clarification: This story has been updated to clarify Wondermed's monthly rate for ketamine lozenges.
From Your Site Articles
- Psychedelic Therapies Are Gaining Steam as Attitudes Change - dot ... ›
- Ketamine for Depression Is Now Available by Injection - dot.LA ›
- Ketamine Clinics Are Opening Across Los Angeles - dot.LA ›
- Pasithea Opens a Chic Clinic in Beverly Hills to Administer Ketamine - dot.LA ›
- New Pasithea Ketamine Clinic In Beverly Hills - dot.LA ›
- Pasithea Opens a Ketamine Clinic In Beverly Hills - dot.LA ›
Related Articles Around the Web
David Shultz
David Shultz reports on clean technology and electric vehicles, among other industries, for dot.LA. His writing has appeared in The Atlantic, Outside, Nautilus and many other publications.
Inside Tinder’s Biggest Product Shift in Years
08:55 AM | March 13, 2026
🔦 Spotlight
Hello Los Angeles,
Despite headlines about swipe fatigue and dating app burnout, Tinder believes the problem isn’t that people are tired of dating. They’re tired of bad dating experiences.
So it felt fitting that Tinder chose the El Rey Theatre in Los Angeles, a venue known for reinvention, to make its case that the category is far from over.
Walking into the El Rey, it was clear Tinder wanted this to feel less like a tech launch and more like a cultural moment. Music was bumping, the room buzzed with chatter and excited energy, red light beams cut through the room, and chandeliers glowed overhead.
At Tinder Sparks 2026: Start Something New, Match Group and Tinder CEO Spencer Rascoff took the stage to outline what the company calls the biggest evolution of the app in years. Tinder remains the largest dating app in the world, used by tens of millions of people across more than 185 countries and responsible for billions of matches every year.

Rascoff framed the shift around a broader cultural reality. In a world where people increasingly interact with machines, technology and AI, the need for real human connection has not gone away. If anything, Tinder believes it has only grown stronger.
To respond to that shift, Tinder says it’s focusing on what it calls “sparks,” the moments when a match actually turns into a real conversation.
As Rascoff put it on stage:
“We are not optimizing for swipes or likes. We are optimizing for sparks.”
That philosophy is shaping a wave of new features discussed throughout the keynote by Tinder’s leadership team, including Mark Kantor, SVP and Head of Product, Yoel Roth, SVP of Trust & Safety, and product leaders Claire Watanabe and Hillary Paine.

Among the updates are Music Mode, which lets users connect through shared songs and artists, and a new Astrology Mode that highlights compatibility between zodiac signs. Tinder is also leaning further into social dating with Double Date, a feature that lets friends match with other pairs together. The feature is already gaining traction with Gen Z users, reflecting a broader shift toward more social and lower-pressure ways to meet people.

Tinder is also redesigning profiles to help users express more personality. New tools can surface stronger photos from a user’s camera roll, improve lighting, and highlight interests more visually, while integrations with platforms like Spotify, Duolingo and the restaurant app Belly bring more of a person’s real life into their profile.

But the most interesting experiment might be happening right here in LA. Tinder is launching IRL Events in the city, letting users browse and RSVP to real-world meetups directly through the app. Think coffee shop raves, trivia nights and pickleball tournaments. The idea is simple. Dating works better when it feels like a social activity instead of an interview.

Under the hood, Tinder is also leaning more heavily on AI to improve recommendations. New tools like Learning Mode and Chemistry aim to better understand what users are actually looking for and surface stronger matches faster. At the same time, the company is investing heavily in safety, expanding Face Check, a facial verification system designed to reduce bots and impersonation accounts.
Closing out the presentation, Melissa Hobley, Tinder’s Chief Marketing Officer, zoomed out from the product roadmap to the brand’s cultural footprint, noting that Tinder is mentioned in billions of TikTok videos and has become shorthand for how younger generations talk about dating.
Taken together, the updates represent Tinder’s most significant evolution in years. And judging by the energy inside the El Rey this week, the company believes the next chapter of dating will be more social, more expressive and more intentional. It’s a shift being shaped right here in Los Angeles, and one that could redefine how the next generation meets.
Now onto this week’s LA venture deals, fund announcements and acquisitions.
🤝 Venture Deals
LA Companies
- Hurray’s GIRL BEER raised a $5M seed round led by Lakehouse Ventures, with participation from Spice Capital plus CPG insiders and entertainment executives, as it accelerates national expansion. The LA-based flavored light beer brand says it has already landed retail placements at Walmart, Kroger, Albertsons, and Whole Foods, and plans to use the new capital to deepen distribution, enter new markets, and ramp up marketing, alongside a rollout of seven new flavors. - learn more
- Freestyle closed a $10M Series A led by Silas Capital, with significant participation from ECP Growth. The company also noted continued backing from existing investors including Mucker Capital, Adapt Ventures, and Superangel, as it scales its premium diapers and wipes business following nationwide launches at Walmart and Target. - learn more
- MAX BioPharma announced a new investment and partnership with Technomark Life Sciences to advance Oxy210, its oxysterol-based, orally available drug candidate for MASH. Technomark is joining as a strategic lead investor by participating in MAX BioPharma’s $13M Series A to fund a Phase 1a/1b first-in-human study, and the companies say the collaboration will pair MAX’s therapeutic platform with Technomark’s drug development experience. - learn more
LA Venture Funds
- B Capital participated in ORO Labs’ $100M Series C, which was led by Brighton Park Capital and Growth Equity at Goldman Sachs Alternatives, as the company pushes deeper into what it calls agentic procurement orchestration. ORO said the new funding follows 300% revenue growth over the past year and will be used to speed up product development, expand go-to-market and customer teams globally, and broaden enterprise use cases across procurement, finance, legal, and supply chain workflows. - learn more
- Aliment Capital participated in Tropic’s oversubscribed $105M Series C, which was co-led by Forbion’s Bioeconomy Fund and Corteva as the company scales the commercial rollout of its gene-edited tropical crops. Tropic said the funding will help expand production of its banana portfolio, accelerate its banana and rice pipelines, and support entry into additional climate-resilient crops, following the 2025 launch of its first new banana varieties in more than 75 years and demand that is already outpacing supply. - learn more
- B Capital doubled down in Axiom’s $200M Series A, which valued the company at more than $1.6 billion and was led by Menlo Ventures. Axiom said the new funding will help it extend its lead from formal mathematics into what it calls “Verified AI,” with plans to apply its technology beyond mathematical discovery into software and hardware verification. - learn more
- WndrCo participated in Quince’s $500M Series E, a round led by ICONIQ that values the manufacturer-to-consumer retail platform at $10.1B post-money. Quince says it will use the fresh capital to accelerate growth and global expansion of its proprietary M2C operating system, which uses AI-driven demand forecasting and direct factory partnerships to cut traditional retail markups. Other investors in the round included Basis Set Ventures, Wellington Management, MarcyPen Capital Partners, Baillie Gifford, Notable Capital, and DST Global. - learn more
- Matter Venture Partners co-led Eridu’s oversubscribed Series A, part of $200M+ raised as the AI networking startup emerges from stealth to tackle what it calls the “network wall” bottleneck in AI data centers. - learn more
- Matter Venture Partners participated in Rhoda AI’s $450M Series A, backing the startup as it comes out of 18 months in stealth with FutureVision, a video-predictive control platform aimed at helping robots operate reliably in messy, real-world industrial environments. The round included a large syndicate of investors, including Capricorn Investment Group, Khosla Ventures, Leitmotif, Mayfield, Premji Invest, Prelude Ventures, Temasek, Xora, and John Doerr, and the company says the funding will accelerate development and industrial deployments. - learn more
- Halogen Ventures participated in Rasa Legal’s $5M late-seed round, backing the company’s push to scale its tech-enabled criminal record sealing and expungement service nationwide. The round was led by Rethink Education with participation from Social Finance and the Richard King Mellon Foundation, and Rasa says the funding will help it expand leadership, speed product development, and grow beyond its current footprint (Utah, Arizona, and Pennsylvania). - learn more
- Halogen Ventures participated in Nyad’s $1.3M oversubscribed pre-seed round, backing the Birmingham-based startup as it launches an AI decision-support tool for wastewater treatment operators. The round was led by Boost VC with participation from Draper Associates, Ollin Ventures, Apprentis, First Avenue Ventures, and strategic angel Troy Wallwork, and Nyad says it will use the funding to hire, grow customers, and keep building the product as retirements thin the wastewater workforce. - learn more
- MANTIS VC participated in Scanner’s $22M Series A, which was led by Sequoia Capital and also included CRV, as the company builds a high-speed security data layer for AI-driven threat investigation. Scanner said the funding comes as security teams at companies like Notion, Ramp, and BeyondTrust use its platform to search years of log data quickly and power agentic workflows that help hunt threats, triage alerts, and investigate incidents more efficiently. - learn more
- Chapter One participated in Zcash Open Development Lab’s $25M+ seed round, joining a syndicate that included Paradigm, a16z crypto, Winklevoss Capital, Coinbase Ventures, Cypherpunk Technologies, and Maelstrom. The new company, formed by former Electric Coin Company team members, said the funding will support continued development of privacy-focused infrastructure for the Zcash ecosystem, including its self-custodial wallet and broader shielded payments tooling. - learn more
- CIV participated in Isembard’s $50M Series A, which was led by Union Square Ventures and also included Tamarack Global, IQ Capital, and existing backer Notion Capital. Isembard said the new funding will help it open 25 AI-powered factories by the end of 2026, expand its engineering team, and enter Germany, France, and Ukraine as it scales software-driven component manufacturing for aerospace and defense customers. - learn more
- WndrCo participated in Crafting’s $5.5M seed round, which was led by Mischief as the startup launched general availability for Crafting for Agents. The company said the new capital will support its push to become core infrastructure for AI-driven engineering teams, giving agents secure access to production-like environments so they can validate, test, and ship code inside complex enterprise systems used by customers including Brex, Faire, and Webflow. - learn more
LA Exits
- Hireguide has been acquired by HireVue, which is buying Hireguide’s underlying technology and bringing the Hireguide team into HireVue’s product org. HireVue says the deal accelerates its agentic AI roadmap, starting with a voice-based AI interviewer designed to help employers qualify candidates earlier and run smarter, more conversational hiring workflows. - learn more
- Ultracor has been acquired by Applied Aerospace & Defense, bringing the California-based maker of specialized honeycomb core materials into Applied’s advanced composites platform. Applied says the deal supports its selective vertical integration strategy by strengthening supply chain control and boosting speed and capacity for space and defense programs, from satellites and missiles to antennas, radomes, and next-gen aircraft. - learn more
Read moreShow less
🔦 Spotlight
Hello, Los Angeles.
This week’s spotlight belongs to a startup chasing one of the biggest and messiest questions in tech right now: where all the power for AI is actually supposed to come from. El Segundo-based Valar Atomics, founded by Isaiah Taylor, is reportedly raising $450 million at a $2 billion valuation to build clusters of small nuclear reactors aimed at powering data centers and other energy-hungry industrial sites.
That is not a subtle ambition. On its website, Valar says it wants to build “hundreds of nuclear reactors” on what it calls gigasites, focusing on grid-independent products including data center power, hydrogen, heavy industrial power, and clean hydrocarbon fuels. Its reactor approach is based on high-temperature gas reactor design principles using TRISO fuel, and the company is explicitly pitching its model as a way to meet the surge in power demand coming from AI.
Valar’s investor roster also helps explain why the company has drawn so much attention. The startup is backed by Palmer Luckey and Palantir CTO Shyam Sankar, and its earlier $130M round in November 2025 was led by Snowpoint Ventures.
What makes the story especially interesting is that this is not just another AI infrastructure company talking about faster chips or more efficient software. It is a bet that the next bottleneck is electricity itself, and that the winning response might look a lot more like hard infrastructure than cloud optimization. In a market full of startups promising to power the future metaphorically, Valar is making a much stranger and bolder claim: it wants to do it literally.
The company is also moving with unusual speed. Valar says it has been selected by the U.S. Department of Energy to achieve criticality on American soil by July 4, 2026 under the administration’s accelerated nuclear program, and related company materials tie its Project NOVA work to the Nuclear Reactor Pilot Program. Whether that timeline proves realistic or not, it tells you something important about the kind of company this wants to be: not a distant science project, but a startup trying to force nuclear power onto AI’s timetable.
And maybe that is the bigger LA angle here. For all the conversation around software, content, and consumer apps, Southern California keeps producing founders who are drawn to the hard stuff: defense, aerospace, energy, logistics, real-world systems with real-world constraints. Valar may still have plenty to prove, but it is hard to accuse this one of thinking small.
Now onto this week’s LA venture deals, fund announcements and acquisitions.
🤝 Venture Deals
LA Venture Funds
- Matter Venture Partners participated in Anvil Robotics’ $5.5M seed round, which it led and which also included Humba Ventures, DNX Ventures, Vivek Sodera, Spacecadet Ventures, and Position Ventures. Anvil said it is building a kind of “Legos for robots” platform for physical AI teams, with open-source custom robots that can ship in one to two days, and has already delivered more than 100 units globally while surpassing seven figures in revenue. - learn more
- WndrCo led daydream’s $15M Series A, backing the AI-native SEO agency alongside First Round Capital and Basis Set Ventures. daydream said the round brings total funding to $21M and will be used to accelerate hiring, product development, and go-to-market expansion as it combines SEO agents with human experts to help companies navigate both traditional search and AI search. - learn more
- Embark Ventures participated in Via Separations’ $36M funding round, which also brought in new strategic backing from Climate Investment, Aramco Ventures, and Marathon Petroleum Corporation. Via said the capital will help deploy more commercial projects and expand its membrane-based industrial filtration platform into refining and chemicals, building on commercial traction in pulp and paper and a pilot completed at a major Gulf Coast refinery. - learn more
- Finality Capital Partners co-led Alien’s $7.1M round alongside Initialized, backing the company’s push to build identity infrastructure for both humans and AI agents. According to the X post announcing the raise, Alien plans to use the funding to develop unique identity systems at a time when proving whether an entity online is human or agentic is becoming increasingly important. - learn more
- M13 participated in OpenFX’s $94M Series A, as the company builds API infrastructure for global FX liquidity. OpenFX said it now moves more than $45B a year across borders, settles 98% of transactions in under 60 minutes, and plans to use the funding to expand its institutional-grade, API-first platform for cross-border payments and treasury operations. - learn more
- M13 led Jimini Health’s $17M seed round, backing the company alongside Town Hall Ventures, LionBird, Zetta Venture Partners, and OneMind as it builds a clinician-supervised AI platform for behavioral health. Jimini said the funding will help scale Sage into more care settings and deepen partnerships with major behavioral health providers across the U.S., positioning it as a safer alternative to unsupervised consumer AI tools for mental health support. - learn more
- MANTIS Venture Capital participated in depthfirst’s $80M Series B, which was led by Meritech Capital and also included Forerunner Ventures, The House Fund, Accel, Box Group, Liquid 2 Ventures, and Alt Capital. The company said the new funding will be used to train additional security models, grow its AI research team, and scale enterprise adoption as it builds an AI-native platform for software security and launches its first in-house security model. - learn more
- Freeflow Ventures participated in TippingPoint Biosciences’ $4.5M seed round, joining SOSV, LKS Fund, Sazze Partners, StoryHouse Ventures, Sontag Innovation Fund, BrightEdge, XEIA Venture Partners, West Coast Angel Network, and others. The company said the financing will help de-risk its epigenetic discovery platform as it works to translate chromatin biology into new therapeutics. - learn more
LA Exits
- Warner Music Group agreed to acquire Revelator, a B2B music platform focused on digital distribution, rights management, royalty accounting, and real-time analytics for independent labels, artists, and distributors. WMG said the deal will strengthen its distribution and label services business, expand the tools available through its labels and ADA, and allow Revelator to keep serving its existing customers while scaling through WMG’s global infrastructure. - learn more
- Omni Agent Solutions has been acquired by Fortress Investment Group, which said the deal will provide long-term capital and resources to expand Omni’s tech-forward platform for bankruptcy and restructuring case administration. Omni said the investment will support continued technology development and scale across services such as claims management, noticing, solicitation support, securities services, disbursements, and call center operations, while its executive and operational teams remain in place. - learn more
- Apium Swarm Robotics is being acquired by Red Cat, adding its distributed control technology for autonomous swarming drones and uncrewed surface vessels to Red Cat’s broader defense platform. Red Cat said Apium will continue operating independently while its autonomy stack is integrated across the business to strengthen coordinated multi-agent operations in contested and communications-degraded environments. - learn more
- HOPWTR is being fully acquired by Constellation Brands, which first invested in the non-alcoholic sparkling water brand through its venture arm in 2021. Constellation said the deal strengthens its no- and low-alcohol portfolio as consumer demand in the space grows, while HOPWTR is expected to keep operating as it does today in the near term with CEO Jordan Bass remaining involved. - learn more
Read moreShow less
RELATEDTRENDING
LA TECH JOBS


